DEEP DIVE

Mass Drug Administration (MDA)

Creation date:

10/10/2018

Last modified date:

30/07/2024

This is an active Deep Dive and we welcome your contributions! If you are currently involved or planning research activities on Mass drug administration (MDA) please contact MESA (mesa@isglobal.org) or add your project to the database.

——

Mass Drug Administration (MDA), defined by WHO as the administration of antimalarial treatment to all age groups of a defined population or every person living in a defined geographical area (except those for whom the medicine is contraindicated) at approximately the same time and often at repeated intervals [ref], has been historically a key component of malaria control and elimination strategies.

In 2015, WHO published recommendations for the use of MDA, mass screening and treatment and focal screening and treatment for malaria [ref]. In the years following the publication of these recommendations and after the release of a practical field manual of MDA for P. falciparum [ref], new studies have been conducted and novel field experience is being acquired. Therefore, WHO convened a meeting to revise and refine the current recommendations for the use of MDA, focusing on its role on decreasing transmission and accelerating progress towards elimination [ref].

With the aim of facilitating the discussions at the Evidence Review Group (ERG) on MDA for malaria held in September 2018 [ref], this deep dive compiles the landscape of recent and ongoing research in antimalarial MDA and provides an overview of the projects’ main characteristics.

MESA Track
Total
projects

0 active
MESA Track
Total funding
amount

MESA Track
Project
sites

Research Area

Total Projects

Project Timeline

Research Area

Total Projects

    Project Timeline

    Research Area

    Total Projects

      Project Timeline

      FILTERS

      Reset filters
      Principal Institutions
      Projects|Funding



      Principal Investigators

        Funding Sources

        Principal Institutions

        Principal Investigators

        Funding Sources

        Principal Institutions


        Latest projects